GHK peptide may host copper (II) ions due to possible copper affinity and may thereby stimulate the synthesis of collagen and increase the accumulation of total proteins and DNA at the injury site
Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Nitric oxide, superoxide, and peroxynitrite in CNS injury
Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist
Oct 2 2021;9(10)doi:10.3390/biomedicines9101378